Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 1
2005 6
2006 3
2007 2
2008 7
2009 6
2010 8
2011 12
2012 5
2013 7
2014 8
2015 6
2016 5
2017 11
2018 9
2019 14
2020 10
2021 12
2022 4
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Higher hemoglobin is better in thalassemia.
Coates TD. Coates TD. Blood. 2024 Mar 7;143(10):842-844. doi: 10.1182/blood.2023023294. Blood. 2024. PMID: 38451517 No abstract available.
Αlpha-thalassemia: A practical overview.
Musallam KM, Cappellini MD, Coates TD, Kuo KHM, Al-Samkari H, Sheth S, Viprakasit V, Taher AT. Musallam KM, et al. Among authors: coates td. Blood Rev. 2024 Mar;64:101165. doi: 10.1016/j.blre.2023.101165. Epub 2024 Jan 3. Blood Rev. 2024. PMID: 38182489 Free article. Review.
Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center.
Hulbert ML, Manwani D, Meier ER, Alvarez OA, Brown RC, Callaghan MU, Campbell AD, Coates TD, Frei-Jones MJ, Hankins JS, Heeney MM, Hsu LL, Lebensburger JD, Quinn CT, Shah N, Smith-Whitley K, Thornburg C, Kanter J. Hulbert ML, et al. Among authors: coates td. Pediatr Blood Cancer. 2023 Jan;70(1):e29961. doi: 10.1002/pbc.29961. Epub 2022 Sep 12. Pediatr Blood Cancer. 2023. PMID: 36094289
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
Taher AT, Cappellini MD, Kattamis A, Voskaridou E, Perrotta S, Piga AG, Filosa A, Porter JB, Coates TD, Forni GL, Thompson AA, Tartaglione I, Musallam KM, Backstrom JT, Esposito O, Giuseppi AC, Kuo WL, Miteva D, Lord-Bessen J, Yucel A, Zinger T, Shetty JK, Viprakasit V; BEYOND Investigators. Taher AT, et al. Among authors: coates td. Lancet Haematol. 2022 Oct;9(10):e733-e744. doi: 10.1016/S2352-3026(22)00208-3. Epub 2022 Aug 22. Lancet Haematol. 2022. PMID: 36007538 Clinical Trial.
129 results